A business can be worth one amount on a standalone basis and support a higher value to a particular buyer if that buyer can create measurable benefits by combining it with existing operations. Those benefits are not automatically part of the seller’s standalone value, and they are not automatically collectible by the seller. Start with a defensible standalone case, then identify buyer-specific cost, revenue, capital, or capability benefits. Estimate when they could occur, subtract implementation costs and uncertainty, and test whether another buyer could create similar benefits. The resulting synergy value is a negotiation range and decision input, not a guaranteed premium or a substitute for qualified financial, legal, or tax advice.
Start with standalone value
Standalone value asks what the business may be worth if it continues under its current plan, ownership, resources, and operating assumptions. It should use maintainable earnings or cash flow, realistic growth, working-capital needs, capital spending, debt, and other factors relevant to the chosen valuation method. The question is what the business contributes on its own, not what an unknown buyer might do after closing.
This separation matters because a buyer may have a different cost structure, distribution footprint, technology, customer base, or access to capital. Damodaran describes synergy as additional value created by combining two entities and recommends valuing each entity independently before comparing that result with the combined business value [2]. For an owner, a standalone case is the baseline against which every buyer-specific claim should be tested.
Define what makes the buyer different
A synergy is not simply a buyer saying that the business is a strategic fit. It is a specific benefit that depends on the combination. Cost synergies might include removing duplicated functions, consolidating facilities, improving purchasing terms, or using an existing platform instead of building a new one. Revenue synergies might include access to a channel, cross-selling capability, geographic reach, or a product that makes a buyer’s existing offering more valuable.
Damodaran groups operating synergies around effects such as scale, pricing power, complementary functional strengths, and higher growth, while financial synergies can affect cash flows or the cost of capital [2]. Use those categories as prompts, not as proof. A claimed benefit needs a clear mechanism, an owner, a timing assumption, and a record that can be checked.
Build a buyer-specific bridge
For each serious buyer, create a bridge from standalone value to potential combined value. Begin with the standalone forecast. Add only benefits that arise from that buyer’s identifiable assets or capabilities. Keep cost savings, incremental revenue, working-capital effects, capital requirements, and financing effects in separate lines so that one optimistic assumption does not hide another.
A useful line-item test is: What changes, why can this buyer make the change, when does it start, and what evidence would show that it happened? A buyer’s internal plan, customer overlap analysis, supplier data, capacity information, or post-close operating plan may support an estimate. A broad statement such as ‘there are many synergies’ does not. The FTC and DOJ’s U.S. Merger Guidelines similarly say that vague or speculative efficiency claims receive no credit in their competition analysis and examine whether claimed benefits are specific to the merger [1]. That guidance is jurisdiction-specific and is not a private-company valuation rule, but its evidence discipline is useful.
Subtract the cost of capturing benefits
A synergy forecast should include the cost of making the benefit real. Common categories include retention arrangements, systems migration, facility changes, duplicate payroll during transition, customer communication, integration management, professional fees, lost productivity, and working capital needed to support growth. The relevant costs depend on the businesses and should come from a documented plan rather than a generic percentage.
Timing matters as much as the headline amount. A benefit that begins later has less value than the same benefit received earlier, and a benefit that requires substantial spending may be worth less than its gross forecast suggests. Separate one-time implementation costs from recurring operating costs. Also identify costs that could fall on the seller before closing or on the buyer after closing, because that distinction can affect negotiation even when it does not change the combined economics.
Model uncertainty instead of one promise
Synergies are forecasts, not cash already earned. Use a base case with a conservative case and an upside case when the evidence supports it. Vary the timing of realization, the percentage of the forecast benefit that is actually captured, the cost of implementation, and the risk that customers or employees react negatively. Do not present a range as a probability unless the basis for that probability is documented.
Check dependencies explicitly. Revenue synergy may require customer consent, new capacity, product changes, or a sales process that takes longer than expected. Cost synergy may depend on employee departures, facility exits, or service-level changes. A buyer may also have alternatives that produce much of the same benefit without acquiring this business. The FTC and DOJ guidelines ask whether alternatives such as contracts, organic growth, or a partial combination could achieve claimed benefits [1]. For a seller, that question helps identify which benefits are truly scarce and which are mainly part of the buyer’s general strategy.
Do not assume the seller captures all synergy value
The combined value of a transaction and the price paid for the business are different questions. The buyer needs enough value left after the purchase price and execution costs to justify taking the risk. The seller is negotiating for a share of the buyer’s value, while also giving up ownership of future upside. If several buyers can create similar benefits, competition may improve the seller’s position. If one buyer is uniquely positioned, that buyer may have more synergy value, but it may also have more leverage unless the process tests alternatives.
A fair discussion separates three numbers: the seller’s standalone value, the buyer’s estimated incremental value, and the portion of that incremental value reflected in the offer. Do not add the full buyer benefit to standalone value and call the result a guaranteed price. The allocation depends on market interest, risk, deal terms, timing, diligence findings, and negotiation. Damodaran emphasizes that synergy value must be considered alongside how the gains are divided between the parties [2].
Use diligence to test the bridge
The seller can make the analysis more credible by organizing evidence that a buyer can verify. Keep customer concentration, retention, pricing, gross margin, employee roles, facility commitments, supplier terms, recurring revenue definitions, working-capital patterns, and capital expenditure records consistent with the standalone forecast. Flag assumptions that are management estimates rather than historical facts.
Ask the buyer to identify the assumptions that are unique to its plan. Which customers overlap? Which functions would be combined? Which systems would be retained? What approvals, contracts, hiring, or investment are required? A public SEC merger filing illustrates why transaction analysis often distinguishes standalone prospects, risks, projections, synergies, and valuation perspectives rather than treating them as one forecast [3]. That filing is an example of public disclosure practice, not a benchmark for a private business and not individual legal advice.
Set review owners and stopping conditions
Assign a human owner to each material assumption. The owner should check the source record, confirm the period and definition, and record whether the item is historical, management-estimated, buyer-provided, or merely illustrative. If software is used to organize documents or compare assumptions, the accountable reviewer remains responsible for checking the underlying records. Do not upload confidential information unless the permitted users, retention choices, and access controls are understood.
Stop or reset the synergy case when a key source cannot be verified, when the buyer changes the scope of the plan, when a required approval or contract is unavailable, or when the benefit depends on a customer or employee response that has not been tested. Human review is especially important before sharing forecasts, accepting a valuation conclusion, or making a disclosure decision.
Turn the analysis into a negotiation question
The useful output is not a single inflated number. It is a buyer-by-buyer schedule showing standalone value, identified benefits, timing, implementation costs, uncertainty, evidence quality, and the value that may reasonably be negotiable. This lets the owner ask focused questions: Which benefits are supported? Which are already in the standalone forecast? Which require the buyer’s unique assets? What must happen after closing? What happens if the benefit arrives late or not at all?
Acquivo is a software platform that delivers the entire sell-side M&A process, valuation, marketing materials, buyer matching, and deal management, on one platform for business owners, M&A attorneys, and boutique investment banks. Acquivo gives business owners the entire sell-side process an investment bank would run, as software, with no success fee. The software is user-operated, so owners and their advisers remain responsible for source checks, permissions, review, and decisions.
Key Points
- Value the business on a standalone basis before adding any buyer-specific benefit.
- Describe each synergy by mechanism, timing, accountable owner, and evidence source.
- Separate cost savings, revenue gains, capital effects, implementation costs, and uncertainty.
- Test whether another buyer, a contract, or organic growth could achieve the same benefit.
- Treat synergy value as a negotiation range, not an automatic premium or guaranteed outcome.
Sources and references
Source retrieval dates record research access, not article publication. Read our editorial and date policy.
- [1] Merger Guidelines (2023) · Accessed
- [2] The Value of Synergy · Accessed
- [3] ITG Definitive Proxy Statement for Merger with Virtu · Accessed
Choose your next step
Acquivo is user-operated software. Owners and their professionals remain responsible for decisions, communications, and professional review.
Educational information, not individual legal, tax, or investment advice. Consult qualified professionals for your circumstances. Acquivo provides software, not representation or negotiation on your behalf.